Duncan joined Kilburn & Strode in September 2018 as an Attorney in the Life Sciences and Chemistry group, having previously worked for another leading firm of patent attorneys.

Duncan is a UK and European patent attorney with experience of coordinating large portfolios across multiple jurisdictions. Duncan has been involved with a number of contentious patent matters, including defence of a key patent covering a blockbuster drug against a large, multi-party EPO opposition. He has also been involved in a number of due diligence and freedom-to-operate projects for both large and small clients.
Duncan has been closely involved with developing the IP strategy of a small biotech firm, including the drafting and prosecution of a number of second medical use patents, and particularly enjoys helping clients to understand and overcome challenges in the patent system. Duncan’s day-to-day workload includes areas such as antibodies, vaccines, protein-based therapeutics, biomarker diagnostics, formulations and certain medical devices.
Duncan graduated with an MSci in Natural Sciences (Biochemistry) from Christ’s College, University of Cambridge before going on to complete a PhD at the MRC London Institute of Medical Sciences. During his PhD he investigated the role of a novel protein kinase in metabolic processes, which involved collaborations with a number of other academics and a pharmaceutical firm.


Chartered UK Patent Attorney
European Patent Attorney 
Certificate in Intellectual Property Law – Queen Mary University
PhD in Medical Biochemistry – Imperial College London
MA/MSci in Natural Sciences (Biochemistry) – University of Cambridge


Chartered Institute of Patent Attorneys (CIPA) 
The Institute of Professional Representatives before the European Patent Office (EPI) 

Cookies improve the way our website works. By using this website you are agreeing to our use of cookies. For more information see our cookie policy I accept